Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2007
08/01/2007EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
08/01/2007EP1373194B1 BENZAMIDE INHIBITORS OF FACTOR Xa
08/01/2007EP1294722B1 Methods of synthesis for 9-substituted hypoxanthine derivatives
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007CN1329394C Novel imidazole derivatives, production method thereof and use thereof
08/01/2007CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders
08/01/2007CN1329379C Anaerobe resistant compound
08/01/2007CN1329378C Compounds useful to treat retroviral infections
08/01/2007CN1329368C Method for the prepararation of enantiomerically enriched compounds
08/01/2007CN1329359C Ether compounds, compositions, and uses thereof
08/01/2007CN101010291A Method for the production of tricyanomethanides of organic cations
07/2007
07/31/2007USRE39754 Benzamide derivatives and pharmaceutical compositions containing same
07/31/2007US7250434 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
07/26/2007WO2007084591A2 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid
07/26/2007WO2007084075A1 Heterogeneous chiral catalyst
07/26/2007WO2007083774A1 Biphenylmethylhydantoin compound, method for producing same, and method for producing biphenylalanine using same
07/26/2007WO2007083538A1 Epoxy bleedout-preventing agent
07/26/2007WO2007083207A1 Substituted imidazoles and their use as pesticides
07/26/2007WO2007083182A2 Novel heterocycles
07/26/2007WO2007083045A1 Compositions based on alkylimidazolidone (meth)acrylates
07/26/2007WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
07/26/2007WO2007082666A1 Acylaminoimidazoles
07/26/2007WO2007017284A3 Inhibitors of cancer cell, t-cell and keratinocyte proliferation
07/26/2007US20070173513 Imidazole compounds
07/26/2007US20070173512 Imidazole compounds
07/26/2007US20070173510 Imidazole compounds
07/26/2007US20070173509 Imidazole compounds
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/26/2007CA2637838A1 Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid
07/26/2007CA2637631A1 Pyrimidine compounds and uses thereof
07/26/2007CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
07/25/2007EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
07/25/2007EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
07/25/2007EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2007EP1263763B1 Tubulin binding ligands
07/25/2007EP1143933B1 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/25/2007CN1328261C Uracil compounds and their use
07/25/2007CN101006062A Imidazolium-methyl sulfites for use as starting compounds for producing ionic liquids
07/25/2007CN101006046A Method for preparing high-purity quaternary ammonium compounds
07/25/2007CN101003510A Purification method of ion liquid
07/24/2007US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport
07/24/2007US7247740 Reacting perfluoroalkanesulfonic acid directly with dialkyl carbonate to give alkyl perfluoroalkanesulfonate optionally in the presence of a water or alcohol consuming reagent, and preparing an alkyl perfluoroalkanesulfonate with an alkylamine or alkylphosphine to prepare perfluoroalkanesulfonic acid
07/24/2007US7247733 By halogen exchange reaction using specific guanidinium, phosphonium or sulfonium catalysts, e.g., diethylaminobis[tris(diethylamino)phosphazenyl]-sulfonium bromide, diethylaminobis(tetramethyl-guanidino)sulfonium bromide and (N,N-dimethylimidazolidino)tetramethyl-guanidinium chloride
07/24/2007US7247732 Method for producing optically active compound
07/24/2007US7247628 Cannabinoid receptor ligands and uses thereof
07/19/2007WO2007079959A1 Substituted propiolic acid amides and their use for producing analgesics
07/19/2007WO2007079958A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
07/19/2007WO2007079927A1 Substituted imidazoline derivatives
07/19/2007WO2007079902A1 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue
07/19/2007WO2007079800A1 Imidazolylmethyl-substituted developers
07/19/2007WO2007035901A3 Bifunctional catalysts for isomerization of unsaturated hydrocarbons
07/19/2007WO2007009083A3 Compounds with activity at retinoic acid receptors
07/19/2007US20070167655 Method for the production of tetrahydrogeranylacetone
07/19/2007US20070167635 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/19/2007US20070167506 Parasiticides of alpha-substituted 2-benzylimidazoles, e.g., 2-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;insecticides; mitacides; ticks and varroa mites; animals; livestock; nontoxic; selectivity for the octopaminergic receptor; pharmakinetics; speed of action; topical spreading; solubility
07/19/2007US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
07/19/2007US20070167481 Imidazonaphthyridines
07/19/2007US20070167456 Mercaptoimidazoles as ccr2 receptor antagonists
07/19/2007DE102006001574A1 Acylaminoimidazole Acylaminoimidazole
07/19/2007CA2633918A1 Substituted imidazoline derivatives
07/19/2007CA2633726A1 Derivatives of 2-nitro-1,3-imidazole coupled to amino acids and deoxyribose useful for the detection of hypoxic biological tissue
07/19/2007CA2633094A1 Substituted propiolic acid amides and their use for producing analgesics
07/19/2007CA2631360A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
07/18/2007EP1807407A1 Aromatic amides as inhibitors of c-fms kinase
07/18/2007EP1807393A1 Diarylsulfones as 5-ht2a antagonists
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007CN1326840C 1-substituted 4-nitroimidazole compound and process for producing the same
07/18/2007CN1326839C 2-substituted-4,4,5,5-tetramethyl-1-hydroxyimidazoline, and its synthesis and use
07/18/2007CN1326832C Double salts of fumaric acid with carnitine and amino acid and food supplements, dietary supplements and drugs contg. same
07/18/2007CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/18/2007CN101001844A Mercaptoimidazoles as CCR2 receptor antagonists
07/18/2007CN100999500A Onitrodazole precursor drug and its preparation process and use
07/18/2007CN100999499A Preparation of CRGA and CRLA by ring-opening polymerization catalyst
07/18/2007CN100999498A Imidazole like ion liquid compound containing amino and preparation process thereof
07/18/2007CN100999497A Oxcarbazepine and synthesizing process of its intermediate
07/17/2007US7244851 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244692 Substituted benzoylcyclohexane diones for use as herbicides
07/17/2007CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/12/2007WO2007078990A2 Modified lysine-mimetic compounds
07/12/2007WO2007077510A2 Muscarinic receptor antagonists
07/12/2007WO2007076709A1 Tri-substituted 1h-imidazolyl compounds, preparation methods, pharmaceutical compositions and pharmaceutical uses thereof
07/12/2007WO2007002639A3 Non-nucleoside anti-hepacivirus agents and uses thereof
07/12/2007US20070161803 Method of asymmetrically reducing 4-[5-(imidazol-1-yl)-2-methylbenzoyl]-3,5- dimethylbenzoic acid or ester thereof
07/12/2007US20070161802 Method for producing 4-nitroimidazole compound
07/12/2007US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
07/12/2007US20070161026 Regents labeled with energy transfer dyes
07/12/2007CA2635335A1 Muscarinic receptor antagonists
07/12/2007CA2634743A1 Modified lysine-mimetic compounds
07/11/2007EP1806343A2 Stable imidazoline solutions
07/11/2007EP1804771A2 Compositions for controlled delivery of pharmaceutically active compounds
07/11/2007EP1651614B1 Method for the production of purified 1,3-substituted imidazolium salts
07/11/2007EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof
07/11/2007CN1325478C Nano structured organic photoelectric material, and preparation method
07/11/2007CN1325477C Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same
07/10/2007US7241790 For wound healing in a warm blooded vertebrate
07/10/2007US7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/10/2007US7241764 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
07/10/2007US7241760 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 345